Trials / Conditions / HLA-A*0201 Positive Cells Present

HLA-A*0201 Positive Cells Present

9 registered clinical trials studyying HLA-A*0201 Positive Cells Present — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma NCT06942442	Sarcoma Alliance for Research through Collaboration	Phase 2
Completed	Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With NCT03450122	M.D. Anderson Cancer Center	Phase 1
Completed	T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer NCT03318900	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Withdrawn	TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Re NCT03506802	Jonsson Comprehensive Cancer Center	Phase 1
Terminated	Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed A NCT02770820	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Terminated	Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Tre NCT03240861	Jonsson Comprehensive Cancer Center	Phase 1
Terminated	Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma NCT02408016	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies NCT02396134	City of Hope Medical Center	Phase 2
Terminated	Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplasti NCT01640301	Fred Hutchinson Cancer Center	Phase 1 / Phase 2